Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Archives of Medical Research|December 10, 2017
Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver TransplantationGuangjun Shi, Chuanxu Wang, Ping Zhang, et al.Biomaterials Science|April 21, 2021
Correction: A mitochondria-targeted dual-functional aggregation-induced emission luminogen for intracellular mitochondrial imaging and photodynamic therapyYujie Zhang, Wendi Huang, Xueying Tan, et al.Biomaterials Science|February 11, 2021
A mitochondria-targeted dual-functional aggregation-induced emission luminogen for intracellular mitochondrial imaging and photodynamic therapyYujie Zhang, Wendi Huang, Xueying Tan, et al.European Journal of Radiology|June 20, 2020
Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancerJing Zhang, Xueying Tan, Xintong Zhang, et al.Oncotargets and Therapy|October 1, 2019
Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathwayDeguo Zhang, Ping Zhang, Luan Li, et al.Oncotarget|January 18, 2018
Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistanceShuanghu Wang, Xueying Tan, Shujuan Li, et al.Drug Delivery and Translational Research|January 12, 2021
Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistanceShuanghu Wang, Xueying Tan, Quan Zhou, et al.Biochemical and Biophysical Research Communications|October 25, 2021
FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathwayHuayuan Liu, Mengya Wang, Zhipeng Jin, et al.Medical Oncology (Northwood, London, England)|April 9, 2025
MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathwayWenJing Cao, XueYing Tan, Xuze Li, et al.Expert Opinion on Pharmacotherapy|July 24, 2019
An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetesJingbo Hu, Chunlin Yang, Hongbo Wang, et al.Pageof 5